大黄素对糖尿病大鼠肾组织基质金属蛋白酶-2及金属蛋白酶组织抑制剂-2表达的影响

被引:24
作者
杨秀 [1 ]
马立彬 [1 ]
谢祥成 [1 ]
张波 [2 ]
杨明 [2 ]
费晓 [1 ]
程明 [2 ]
王鸣 [1 ]
梅长林 [2 ]
机构
[1] 杭州市第一人民医院肾内科
[2] 第二军医大学附属长征医院肾内科
关键词
基质金属蛋白酶-2; 金属蛋白酶组织抑制剂-2; 糖尿病; 糖尿病肾病; 大黄素;
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
100201 [内科学];
摘要
目的探讨大黄素对糖尿病大鼠肾组织基质金属蛋白酶-2(MMP-2)/金属蛋白酶组织抑制剂-2(TIMP-2)表达的影响。方法实验大鼠随机分为健康对照(NC)组、糖尿病模型(DM)组及大黄素治疗(DM+Emodin)组(40mg/kg),各12只。至36周时处死所有大鼠,收集血、尿标本,检测生化指标和24hUAlb;取肾组织标本,采用RT-PCR和Western blot检测相关mRNA及蛋白。结果 36周时,与NC组比较,DM组和DM+Emodin组血糖[(6.44±0.83)vs(33.11±3.02),(32.39±2.78)mmol/L]、HbA1c[(5.6±0.6)%vs(18.0±3.2)%,(20.1±3.3)%]、SBP[(108±9)vs(131±14),(131±8)mmHg]、肾重/体重比[(5.3±0.6)vs(11.5±1.0),(10.4±1.3)]、eGFR[(5.9±1.2)vs(12.9±2.2),(11.2±1.2)ml/(min·173m2)]及UAlb[(3.3±1.8)vs(52.8±30.1),(26.6±10.5)mg/24h]升高(P<0.001),DM+Emtin组肾重/体重比、eGFR及UAlb均低于DM组(P<0.05或P<0.01)。与DM组比较,DM+Emodin组MMP-2 mRNA[(1.43±0.36)vs(1.13±0.19),P<0.05]、TIMP-2 mRNA[(1.70±0.27)vs(1.23±0.18),P<0.001]上调现象被抑制,且MMP-2[(2.45±0.24)vs(2.98±0.55),P<0.01]、TIMP-2[(2.07±0.30)vs(1.59±0.37),P<0.001]蛋白表达水平下调。结论大黄素可以减少糖尿病大鼠肾组织中MMP-2/TIMP-2表达,减少蛋白尿,可能延缓DN进展。
引用
收藏
页码:159 / 162
页数:4
相关论文
共 7 条
[1]
The anthraquinone derivative Emodin inhibits angiogenesis and metastasis through downregulating Runx2 activity in breast cancer [J].
Ma, Junchao ;
Li, Hong ;
Wang, Shan ;
Chen, Bin ;
Liu, Zhaojie ;
Ke, Xiaoqin ;
Liu, Ting ;
Fu, Jianjiang .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (04) :1619-1628
[2]
Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620.[J].Thacker Pooja;Devarajan Karunagaran.European Journal of Pharmacology.2014,
[3]
Emodin; a Naturally Occurring Anthraquinone Derivative; Ameliorates Dyslipidemia by Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed Rats.[J].Thing-Fong Tzeng;Hung-Jen Lu;Shorong-Shii Liou;Chia Ju Chang;I-Min Liu;Angelo Antonio Izzo.Evidence-Based Complementary and Alternative Medicine.2012,
[4]
Diabetes-Induced Alterations in the Extracellular Matrix and Their Impact on Myocardial Function [J].
Law, Brittany ;
Fowlkes, Vennece ;
Goldsmith, Jack G. ;
Carver, Wayne ;
Goldsmith, Edie C. .
MICROSCOPY AND MICROANALYSIS, 2012, 18 (01) :22-34
[5]
The Interaction of Amyloid β and the Receptor for Advanced Glycation Endproducts Induces Matrix Metalloproteinase-2 Expression in Brain Endothelial Cells [J].
Du, Huan ;
Li, Pengtao ;
Wang, Jun ;
Qing, Xuemei ;
Li, Weihong .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2012, 32 (01) :141-147
[6]
Circulating Matrix Metalloproteinase-2 Is an Independent Correlate of Proteinuria in Patients with Chronic Kidney Disease [J].
Nagano, Makio ;
Fukami, Kei ;
Yamagishi, Sho-ichi ;
Ueda, Seiji ;
Kaida, Yusuke ;
Matsumoto, Takafumi ;
Yoshimura, Junko ;
Hazama, Takuma ;
Takamiya, Yoshimi ;
Kusumoto, Takuo ;
Gohara, Shojiro ;
Tanaka, Hideharu ;
Adachi, Hisashi ;
Okuda, Seiya .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (02) :109-115
[7]
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy [J].
Wendt, TM ;
Tanji, N ;
Guo, JC ;
Kislinger, TR ;
Qu, W ;
Lu, Y ;
Bucciarelli, LG ;
Rong, LL ;
Moser, B ;
Markowitz, GS ;
Stein, G ;
Bierhaus, A ;
Liliensiek, B ;
Arnold, B ;
Nawroth, PP ;
Stern, DM ;
D'Agati, VD ;
Schmidt, AM .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1123-1137